Left ventricular noncompaction (LVNC) is a rare disorder in which the left ventricular endocardial surface is not appropriately flattened and is heavily trabeculated. Patients with this condition can be affected by stroke from emboli that originate from these recesses. We present a patient with LVNC who was originally misdiagnosed as having an idiopathic dilated cardiomyopathy. Ultimately, diagnosis of LVNC was confirmed through the use of 64-slice multidetector cardiac computed tomography (CT). There are few reports of using multidetector CT for diagnosis of LVNC, but this appears to be a viable option in confirming the diagnosis and at the same time assessing the coronary arteries. The recognition of this cardiomyopathy and its differentiation from other nonischemic cardiomyopathies have important implications for the patient and for family members, given its potential familial inheritance patterns and poor long-term prognosis.
Left ventricular noncompaction (LVNC) is a rare disorder in which the left ventricular endocardial surface is not appropriately flattened and is heavily trabeculated. Patients with this condition can be affected by stroke from emboli that originate from these recesses. We present a patient with LVNC who was originally misdiagnosed as having an idiopathic dilated cardiomyopathy. Ultimately, diagnosis of LVNC was confirmed through the use of 64-slice multidetector cardiac computed tomography (CT). There are few reports of using multidetector CT for diagnosis of LVNC, but this appears to be a viable option in confirming the diagnosis and at the same time assessing the coronary arteries. The recognition of this cardiomyopathy and its differentiation from other nonischemic cardiomyopathies have important implications for the patient and for family members, given its potential familial inheritance patterns and poor long-term prognosis.
CASE REPORT
A 31-year-old man was diagnosed with heart failure in 2008 when he was 27 years old. Coronary angiography did not show signifi cant narrowing, and he was treated medically. He was diagnosed in 2011 with diabetes mellitus type 2 and around that time presented to a regional hospital with a large leftsided stroke and a smaller right-sided stroke, both believed to be embolic in origin. Transthoracic and then transesophageal echocardiography reconfi rmed severely dilated ventricular cavities and echogenicity in the left ventricular apex, suspicious for recanalized thrombus. Transesophageal echocardiography also suggested the incidental fi nding of a bicuspid aortic valve.
Th e patient was started on warfarin. He gradually improved but was left with mild dysarthria and left-sided weakness. In 2012, he sought care at Baylor University Medical Center at Dallas. Repeat echocardiogram showed excessive trabeculation of the left ventricular endocardium, consistent with a diagnosis of left ventricular noncompaction (LVNC) (Figure) .
A 64-slice gated multidetector computed tomography (CT) scan of the heart (Lightspeed VCT, GE Healthcare) confi rmed both the lack of coronary narrowing and the presence of excessively trabeculated endocardium, at least 2.5 times the thickness of the compacted portion of the left ventricular wall. Th e patient was treated medically. An implantable cardioverter defi brillator (ICD) was placed for primary prevention of sudden cardiac death.
DISCUSSION
LVNC is a morphologic abnormality of the left ventricular myocardium characterized by a failure of the left ventricular myocardium to appropriately form. It is exemplifi ed by a ventricular wall with prominent trabeculations and deep intertrabecular recesses. Th is abnormality is thought to be secondary to the intrauterine arrest of myocardial compaction that occurs in the early stages of fetal development resulting in two layers of myocardium, a compacted and a noncompacted layer (1, 2) . Th ere is continuity between the ventricular cavity and the intertrabecular recesses of the trabeculated layer. A reduction in ejection fraction and decrease in the coronary fl ow reserve are often observed in segments with wall motion abnormalities (3).
LVNC is classifi ed as a primary genetic cardiomyopathy by the American Heart Association (4). However, a recent comprehensive review by Oechslin and Jenni (5) concluded that the paradigm of LVNC being a specifi c disease entity should be revisited and that LVNC might just be a morphological expression or a phenotypic variant of other cardiomyopathies of a primary genetic disorder.
At necropsy, a variety of gross patterns of noncompaction have been noted, including coarse trabeculae resembling multiple papillary muscles and sponge-like, interlacing, smaller muscle bundles (6, 7) . Histologic fi ndings are nonspecifi c, and most studies have described the presence of necrosis and interstitial fi brosis in endomyocardial biopsy (8, 9) .
Th e prevalence of adult LVNC ranges from 0.01% to 0.27% (1, 10) . A review from Switzerland identifi ed 34 cases within 15 years in a population of patients who underwent echocardiographic examination, which represented 0.014% of the echocardiograms (11) . Th e prevalence of the disease was around 18% to 50% among members of aff ected families (12) . In one large center, the prevalence of LVNC was reported as 3% among 960 patients with heart failure (13) .
Several cardiac abnormalities may be associated with noncompaction of the myocardium, including congenital right or left ventricular outfl ow tract abnormalities, such as pulmonary atresia with intact ventricular septum (14) . Coronary artery abnormalities, common in right or left ventricular outfl ow tract abnormalities, are typically not seen in isolated LVNC (15) . Other associations with LVNC have included Ebstein's anomaly, bicuspid aortic valve, aorta-to-left-ventricular tunnel, and transposition of the great vessels (16, 17) .
Th e clinical manifestations of LVNC vary widely. Patients may be asymptomatic or have symptoms of heart failure, arrhythmias, or thromboembolism (18, 19) . Electrocardiographic abnormalities include bundle branch block and arrhythmias, such as atrial fi brillation and ventricular tachycardia. Association with bradycardia and Wolff Parkinson White syndrome was described in 18% of pediatric patients with LVNC (20) .
Th e diagnosis of LVNC is often made by echocardiography, which is often the fi rst diagnostic method used. Other nonspecifi c fi ndings that can be seen on echocardiography include reduced global left ventricular systolic function, left ventricular diastolic dysfunction, left ventricular thrombi, and abnormal papillary muscle structure (9) . Th e diagnostic criteria to confi rm LVNC are summarized in the Table (9, 21, 22) ; the criteria most often used are those proposed by Jenni et al, a ratio of compacted to noncompacted myocardium >2 (9) .
Cardiac magnetic resonance imaging (CMRI) can play an important role in confi rming the diagnosis, especially diff erentiating trabeculae from aberrant bands, false tendons, and abnormal insertion of papillary muscles. Compared with CMRI, echocardiography underestimated the ratio of noncompacted to compacted myocardium (23) .
Contrast-enhanced CT is capable of showing the abnormal architecture of the left ventricular wall in noncompaction. CT also enables quantitative and qualitative assessment of global and regional ventricular function. Additionally, CT can be used to evaluate the coronary arteries to exclude anomalies or coronary artery disease, which is usually not feasible with CMRI or echocardiography (24) .
The prevention of thromboembolic complications has been the subject of debate. Some authors have recommended prophylactic anticoagulation for all patients diagnosed with LVNC, regardless of ventricular function (1, 11) . Other guidelines recommend anticoagulation for patients with decreased (21) Presence of x / y < 0.5, where: X = distance from the epicardial surface to the trabecular recess; Y = distance from the epicardial surface to the peak of trabeculations.
These criteria are applied to trabeculations of the left ventricular apex with subxiphoid or apical fourchamber views at the end of diastole.
Stollberger et al (22)
• systolic function with ejection fractions <40%, a history of thromboembolism, or atrial fi brillation (12) . ICD implantation is also indicated for primary prevention in patients with LVNC with a left ventricular ejection fraction ≤35% and New York Heart Association class II to III heart failure. However, there have been a few reports of unsuccessful defi brillation by an ICD in LVNC (25) . Patients with LVNC who have endstage heart failure are candidates for cardiac transplantation; successful cardiac transplantation in those patients has been reported (7).
